LY2590443 / Eli Lilly  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LY2590443 / Eli Lilly
NCT00804973: Study in Participants With Acute Migraines Headaches

Terminated
2
120
US
LY2590443, Placebo injection, Sumatriptan, Placebo capsule
Eli Lilly and Company
Migraine Headache
05/09
05/09

Download Options